Research Article

A Pilot Trial of Stepwise Implementation of Virtual Reality Mindfulness and Accelerated Transcranial Magnetic Stimulation Treatments for Dysphoria in Neuropsychiatric Disorders

Table 1

Clinician- and self-rated scales completed throughout the study.

AssessmentsVR
visit 1
VR
visit 5
VR
visit 10
TMS
TxA1
TMS
TxA5
TMS
FxA1–A5
TMS
TxB1
TMS
TxB5
TMS
FxB1–B5

DemographicsXXX
SF-36XXXXXXXXX
PHQ-9XXXXXXXXX
GAD-7XXXXXXXXX
PCL-5XXXXXXXXX
LEC-5XXX
PROMIS pain intensityXXXXXXXXX
PROMIS sleepXXXXXXXXX
PROMIS fatigueXXXXXXXXX
DARSXXXXXXXXX
POMSXXXXXXXXX
SETSXXX
Stanford hypersensitivity scaleXX
MAIAXX
User experienceXX
TMS safety screenXXX
MADRSXXXXXX
HAM-AXXXXXX
CAPS-5XXXXXX
PROMIS pain interferenceXXXXXX
YMRSXXXXXX
C-SSRSXXXXXX
Medical historyXXX
Clinical interviewXXXXXX
Urine drug and pregnancy screenX

Bold indicates self-rated scales, and italic indicates clinician-rated scales. SF-36 = 36-item short form survey; PHQ-9 = patient health questionnaire-9; GAD-7 = generalized anxiety disorder-7; PCL-5 = PTSD checklist for DSM-5; LEC-5 = life events checklist for DSM-5; PROMIS = patient-reported outcomes measurement information system; DARS = dimensional anhedonia rating scale; POMS = profile of mood states; SETS = Stanford expectations of treatment scale; MAIA = multidimensional assessment of interoceptive awareness; MADRS = Montgomery-Asperg depression rating scale; HAM-A = Hamilton anxiety rating scale; CAPS-5 = clinician-administered PTSD scale for DSM-5; YMRS = Young mania rating scale; C-SSRS = Columbia suicide severity rating scale).